Korean Biopharma Beefs Up Open Innovation to Raise Pipelines’ Value
The Korea Biomedical Review reported that Korean pharmaceutical and biotech companies are using various open innovation tools to raise competitiveness in new drug development in the global market. In the past, Korean drugmakers conducted research in secrecy due to the risk of technology leakage. But now, they actively get technologies and business
Comments Off on Korean Biopharma Beefs Up Open Innovation to Raise Pipelines’ Value • Read this story »